Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke: Correlations of outcome with clinical and radiological data

Stroke

Volumn 27, Issue 5, 1996, Pages 882-890

  Trouillas, Paul ^a   Nighoghossian, Norbert ^a   Getenet, Jean Claude ^a   Riche, Georges ^a   Neuschwander, Philippe ^a   Froment, Jean Claude ^a   Turjman, Francis ^a   Jin, Jia Xiang ^a   Malicier, Daniel ^b   Fournier, Gerard ^b   Gabry, André Louis ^e   Ledoux, Xavier ^e   Derex, Laurent ^a   Berthezène, Yves ^a   Adeleine, Patrice ^c   Xie, Jing ^a   Ffrench, Patrick ^d   Dechavanne, Marc ^d  

^a HÔPITAL NEUROLOGIQUE   (France)

^b South Lyon Hospital   (France)

^c UNIVERSITÉ LYON 1   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e Emergency Units of Lyon Hospitals   (France)

Author keywords

heparin; mannitol; plasminogen activator, tissue type; thrombolytic therapy; tomography, emission computed

Indexed keywords

ALTEPLASE; HEPARIN; MANNITOL;

ADULT; AGED; ARTICLE; CAROTID ARTERY OBSTRUCTION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROPATHOLOGY; NEURORADIOLOGY; NEUROTOXICITY; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STROKE; TREATMENT OUTCOME;

EID: 9244240262     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.5.882     Document Type: Article

References (43)

1. Zeumer H, Freitag HJ, Brzyska U, Nunzig HP. Local intraarterial fibrinolysis in acute vertebrobasilar occlusion: technical developments and recent results. Neuroradiology. 1989;3:336-340.
2. Miyakawa T, Sakuragawa N. The cerebral vessels and thrombosis. Rinsho Ketsueki. 1984;2:1001-1026.
3. Zeumer H. Vascular recanalising techniques in interventional neuroradiology. J Neurol. 1985;231:287-294.
4. Maiza D, Theron J, Pelouze GA, Casasco A, Courtheoux P, Derlon JM, Mercier V, Petetin L, Everard C. Local fibrinolytic therapy in ischemic carotid pathology. Ann Vasc Surg. 1988;2:205-214.
5. del Zoppo GJ, Ferbert A, Otis S, Bruckmann H, Hacke W, Zyroff J, Harker L, Zeumer H. Local intraarterial fibrinolytic therapy in acute carotid territory stroke: a pilot study. Stroke. 1988;19:307-313.
6. Hacke W, Zeumer H, Ferbert A, Bruckmann H, del Zoppo GJ. Intraarterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke. 1988;19:1216-1222.
7. Theron J, Courtheoux P, Casasco A, Alachkar F, Notari F, Ganem F, Maiza D. Local intraarterial fibrinolysis in the carotid territory. AJNR Am J Neuroradiol. 1989;10:753-765.
8. Lehmann R, Zschenderllein R, Gromnica-Ihle E, Ziemer S. Lokale intravasale Fibrinolyse (LIF) bei akuten zerebrovascularen Vershlussen. Radio Diagn. 1989;30:481-488.
9. Mori E, Tabuchi M, Yoshida T, Yamadori A. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke. 1988;19:802-812.
10. Mori E, Tabuchi M, Yoshida T, Yamadori A. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke. 1988;19:802-812.
11. Mori E, Tabuchi M, Ohsumi Y, Yoshida T, Ohkawa S, Yoneda Y, Yamadori A. Intraarterial urokinase infusion therapy in acute thromboembolic stroke. Stroke. 1990;21(suppl I):I-74. Abstract.
12. Mori E. Fibrinolytic recanalization therapy in acute cerebrovascular thromboembolism. In: Hacke W, del Zoppo GJ, Hirschberg M, eds. Thrombolytic Therapy in Acute Ischemic Stroke. New York, NY: Springer-Verlag; 1991:207-212.
13. Ikeda S, Muraishi K. Intracranial major artery occlusion. Stroke. 1990;21(suppl I):I-95-I-96.
14. Berg-Dammer E, Topper R, Mobius E, Nahser HC, Kuhne D. Local thrombolytic therapy of thromboembolic occlusion of the middle cerebral artery. In: Proceedings of the Second International Conference on Acute Stroke; June 1-2, 1991; Geneva, Switzerland; 62.
15. Siepmann G, Muller-Jenscn M, Gossens H, Lachenmeyer L, Zeumer H. Local intraarterial fibrinolysis in acute middle cerebral artery occlusion. Neuroradiology. 1991;33(suppl):69-71.
16. Möbius E, Berg-Dammer E, Kuhne D, Nahser HC. Local thrombolytic therapy in acute basilar artery occlusion: experience with 18 patients. In: Hacke W, del Zoppo GJ, Hirschberg M, eds. Thrombolytic Therapy in Acute Ischemic Stroke. New York, NY: Springer-Verlag; 1991:213-215.
17. Seikmann R, Wakhloo AK, Schumacher M. Local intraarterial thrombolysis in old patients. In: Proceedings of the Second International Conference on Acute Stroke; June 1-2, 1991; Geneva, Switzerland.
18. Matsumoto K, Satoh K. Topical intraarterial urokinase infusion for acute stroke. In: Hacke W, del Zoppo GJ, Herschberg M, eds. Thrombolytic Therapy in Acute Ischemic Stroke. New York, NY: Springer-Verlag; 1991:207-212.
19. Yamaguchi T, Hayakawa T, Kikuchi H, Abe T. Thrombolytic therapy in embolic and thrombotic cerebral infarction: a cooperative study. In: Hacke W, del Zoppo GJ, Hirschberg M, eds. Thrombolytic Therapy in Acute Ischemic Stroke. New York, NY: Springer-Verlag; 1991:168-174.
20. Baird AE, Donnan GA, Austin MC, Fitt GJ, McKay WJ. HMPAO SPECT measures reperfusion after thrombolytic therapy in acute stroke. In: del Zoppo GJ, Mori E, Hacke W, eds. Thrombolytic Therapy in Acute Ischemic Stroke II. New York, NY: Springer-Verlag; 1993:301-303.
21. Williams MA, Razumovshy AY, Diringer MN, Monsein LH, Debrun GM, Bryan RN, Hanley DF. Transcranial Doppler sonographic (TCD) monitoring of basilar artery thrombolysis. In: del Zoppo GJ, Mori E, Hacke W. Thrombolytic Therapy in Acute Ischemic Stroke II. New York, NY: Springer-Verlag; 1993:298-300.
22. Von Kummer R, Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke. 1992;23:646-652.
23. Brott TG, Haley EC Jr, Levy DE, Barsan W, Broderick J, Sheppard GL, Spilker J, Kongable GL, Massey S, Reed R, Marier JR. Urgent therapy for stroke, part I: pilot study for tissue plasminogen activator administered within 90 minutes. Stroke. 1992;23:632-640.
24. Haley EC Jr, Levy DE, Brott TG, Sheppard GL, Wong MCW, Kongable GL, Torner JC, Marier JR. Urgent therapy for stroke, part II: pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke. 1992;23:641-645.
25. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Greenlee R Jr, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gross D, Otis SM. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:78-86.
26. Yamaguchi T, Hayakawa T, Kikuchi H. Intravenous tissue plasminogen activator in acute thromboembolic stroke: a placebo-controlled, double blind trial. In: del Zoppo GJ, Mori E, Hacke W, eds. Thrombolytic Therapy in Acute Ischemic Stroke II. New York, NY: Springer-Verlag; 1993:59-65.
27. Mori E, Yoneda Y, Tabuchi M, Yoshida T, Ohkawa S, Oshumi Y, Kitano K, Tsutsumi A, Yamadori A. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology. 1992;42:976-982.
28. Haley EC Jr, Brott TG, Sheppard GL, Barsan W, Broderick J, Marier JR, Kongable GL, Spilker J, Massey S, Hansen CA, Torner JC. Pilot randomized trial of tissue plasminogen in acute ischemic stroke. Stroke. 1993;24:1000-1004.
29. Lindenstrom E, Boysen G, Christiansen LW, Hansen BR, Nielsen PW. Reliability of Scandinavian Neurological Stroke Scale. Cerebrovasc Dis. 1991;23:646-652.
30. Saito I, Segawa H, Shikawa Y, Taniguchi M, Tsutsumi K. Middle cerebral artery occlusion: correlation of computed tomography and angiography with clinical outcome. Stroke. 1987;18:863-868.
31. Yoshimoto T, Ogawa A, Seki H, Kogure T, Suzuki J. Clinical course of acute middle cerebral artery occlusion. J Neurosurg. 1986; 65:326-330.
32. Ueda S, Fujitsu K, Inomori S, Kuwabara T. Thrombotic occlusion of the middle cerebral artery. Stroke. 1992;23:1761-1766.
33. Damasio H. A computed tomographic guide to the identification of cerebral vascular territories. Arch Neurol. 1983;40:138-142.
34. Hupperts RMM, Lodder J, Heuts-van Raak EM, Kessels F. Infarcts in the anterior choroidal artery territory: anatomical distribution, clinical syndromes, presumed pathogenesis and early outcome. Brain. 1994;117:825-834.
35. Pessin MS. Hemorrhagic transformation in the natural history of acute embolic stroke. In: Hacke W, del Zoppo GJ, Hirschberg M, eds. Thrombolytic Therapy in Acute Ischemic Stroke. New York, NY: Springer-Verlag; 1991:67-74.
36. Marder VJ, Sherry S. Thrombolytic therapy: current status. N Engl J Med. 1988;318:1585-1595.
37. Levy DE, Brott TG, Haley EC, Marler JR, Sheppard GL, Barsan W, Broderick P. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke. 1994;25:291-297.
38. Touzani O, Young AR, Derlon JM, Baron JC, MacKenzie ET. Reversible middle cerebral artery occlusion (MCAO) in anesthetized baboons: serial metabolic studies with PET. Cerebrovasc Dis. 1995;5:230. Abstract.
39. Overgaard K, Sperling B, Boysen G, Pedersen H, Gam J, Ellemann K, Karle A, Arlien-Soborg P, Olsen TS, Videbaek Ch, Knudsen JB. Thrombolytic therapy in acute ischemic stroke: a Danish pilot study. Stroke. 1993;24:1439-1446.
40. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemie stroke. N Engl J Med. 1995;333:1581-1587.
41. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, Von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH, Hennerici M, for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA. 1995;274:1017-1025.
42. Koudstaal PJ, Stibbe J, Vermeulen M. Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator in acute stroke. Br Med J. 1988;297:1571-1574.
43. Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, Gregory J, del Zoppo GJ, and the rt-PA Acute Stroke Study Group. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol. 1993;14:32-43.